eye treatment biosimilar
Scope
Date
~
-
Robotics
Samsung raises Rainbow Robotics stake, eyes management control
Samsung Electronics Co. is looking to own a controlling stake in Rainbow Robotics Co., a South Korean collaborative robot maker, as the tech giant h...
Mar 16, 2023 (Gmt+09:00)
-
Business & Politics
South Korea eyes $261 billion chip cluster; Samsung takes lead
South Korea said on Wednesday it will create the world’s largest semiconductor cluster near Seoul by attracting 340 trillion won ($261 billion...
Mar 15, 2023 (Gmt+09:00)
-
Aerospace & Defense
Boeing’s Korean supplier targets UAV market with guided weapons
Boeing Co.’s leading South Korean contractor aims to develop unmanned aerial vehicles with guided weapons, given the rapidly growing military ...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong wins approval for GERD treatment Fexuclu in Chile
South Korean pharmaceutical company Daewoong Pharmaceutical announced on Tuesday that it has received marketing authorization from Chile's National ...
Mar 14, 2023 (Gmt+09:00)
-
Travel & Leisure
H2O Hospitality rebrands itself as it eyes Middle East expansion
H2O Hospitality, a hospitality tech company that provides digital solutions for the hotel and tourism industry, said on Tuesday that it has rebrande...
Mar 10, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung, Arm partner Gaonchips eyes US as next offshore base
Gaonchips Co., a long-term Samsung Electronics Co’s chip design house partner that also works with British fabless chip company Arm Inc., will...
Mar 10, 2023 (Gmt+09:00)
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Upcoming IPOs
Korea’s sole foreign clinic operator CHA Healthcare to go public in 2025
CHA Healthcare Co. operating nearly 90 hospitals and infertility treatment centers across the world, is set to pave the way for South Koreans' inves...
Mar 08, 2023 (Gmt+09:00)
-
Electric vehicles
Hyundai eyes greater SUV market share with new Kona EV
Hyundai Motor Co. on Tuesday unveiled the all-new Kona Electric, its first fully revamped compact sport utility vehicle in five years, as the top So...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada
Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion ex-Chairman Seo set to return to management; group stocks rally
South Korea’s biosimilar giant Celltrion Group’s founder and Honorary Chairman Seo Jung-jin is readying to return to management just two...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Cha Biotech sells eye-cell technology to Japan's Astellas for $32 mn
Cha Biotech, a South Korean biotechnology company, said on Thursday that it agreed to sell its technology for developing eye-cell therapies to Astel...
Mar 03, 2023 (Gmt+09:00)
-
IPOs
Battery material maker EcoPro Materials eyes $2.3 billion IPO
EcoPro Materials Co., a unit of South Korea’s battery materials group EcoPro Group, is looking to list its shares on the country’s main ...
Feb 28, 2023 (Gmt+09:00)
-
Batteries
Samsung leader eyes solid-state batteries as future growth engine
Samsung Group appears set to up its investment in solid-state batteries, a game changer in the electric vehicle sector, as South Korea’s top c...
Feb 27, 2023 (Gmt+09:00)
-
Private equity
S.Korean investors eye VC, growth equity in tech: Adams Street
Many investors are questioning whether private markets will stay bullish amid uncertainty in 2023. The markets will continue to generate interesting...
Feb 23, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung eyes wider foundry client base with Ambarella deal
Samsung Electronics Co., the world’s largest memory chipmaker, said on Tuesday it will manufacture automotive chips for US chip designer Ambar...
Feb 21, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung leader eyes memory chip packaging investment
Samsung Electronics Co., the world’s largest memory chipmaker, may accelerate investment in leading-edge technologies including chip packaging...
Feb 17, 2023 (Gmt+09:00)
-
Economy
Korean shipbuilding, defense sectors offer bright 2023 outlook
South Korea’s major companies in shipbuilding, defense and construction industries expect strong earnings this year, despite growing concerns ...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
AIMMED’s Somzz ushers in digital therapeutic device market in Korea
South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Plasma, Janssen Korea sign sales, distribution agreement
SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...
Feb 14, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung, SK Hynix: key beneficiaries of ChatGPT fever
Samsung Electronics Co. and SK Hynix Inc., the world’s two largest memory chipmakers, stand to benefit from the global popularity of ChatGPT. ...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanall Biopharma invests in Interon Labs for brain disease treatments
South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's Herceptin biosimilar proves equivalence in clinical trials
Prestige Biopharma, a South Korean biopharmaceutical developer, said on Tuesday that the final analysis of phase 3 clinical trial on the anti-cancer...
Feb 08, 2023 (Gmt+09:00)
-
Earnings
SKC eyes M&As in semiconductor, rechargeable battery materials
SKC Inc., a South Korean chemical materials company under SK Group, is seeking to buy semiconductor and rechargeable battery materials companies in ...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Electric vehicles
LG Elec eyes profit from EV powertrain, car lighting biz
LG Electronics Inc., the world’s leading home appliance maker, aims to take profit from the electric vehicle powertrain and car lighting units...
Jan 31, 2023 (Gmt+09:00)
-
Earnings
Samsung vows no chip output cut, eyes second-half demand recovery
Samsung Electronics Co. said on Tuesday it has no plans to cut semiconductor production even if it incurs temporary losses as the world’s larg...
Jan 31, 2023 (Gmt+09:00)